BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors. Issue 3 (4th March 2021)

Record Type:: Journal Article
Title:: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors. Issue 3 (4th March 2021)
Main Title:: BCL2L2 loss renders ‐14q renal cancer dependent on BCL2L1 that mediates resistance to tyrosine kinase inhibitors
Authors:: Lyu, Yinfeng
Li, Kunping
Li, Yuqing
Wen, Hui
Feng, Chenchen
Abstract:
Is Part Of:: Clinical and translational medicine. Volume 11:Issue 3(2021)
Journal:: Clinical and translational medicine
Issue:: Volume 11:Issue 3(2021)
Issue Display:: Volume 11, Issue 3 (2021)
Year:: 2021
Volume:: 11
Issue:: 3
Issue Sort Value:: 2021-0011-0003-0000
Page Start:: n/a
Page End:: n/a
Publication Date:: 2021-03-04
Subjects:: Clinical medicine -- Periodicals
Medicine, Experimental -- Periodicals
Medical innovations -- Periodicals
Molecular biology -- Periodicals
Pathology, Molecular -- Periodicals
616.027
Journal URLs:: https://onlinelibrary.wiley.com/loi/20011326 ↗
http://www.clintransmed.com/content ↗
http://www.biomedcentral.com/journals/#C ↗
http://www.springer.com/gb/ ↗
DOI:: 10.1002/ctm2.348 ↗
Languages:: English
ISSNs:: 2001-1326
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 16232.xml